“This is the Judgment Day that we all predicted while sharing a conspiratorial joint in the dark days of prohibition. It’s surreal to see our fears manifesting in real time.” By Deb Tharp, NuggMD Politico recently published an extensive Q&A with Howard Sklamberg, a former top Food and Drug Administration (FDA) official who currently works […]| Marijuana Moment
A day after the Drug Enforcement Administration’s (DEA) decision that marijuana will move to the less-restrictive Schedule III of the Controlled Substances Act, a leading cannabis prohibition group sent an email to supporters asking for money to fuel its fight against the reform. “SAM will oppose this change at every level, including, if necessary, pursuing […]| Marijuana Moment
The Drug Enforcement Administration (DEA) is telling lawmakers that it reserves “the final authority” to make any scheduling decision on marijuana following an ongoing review, regardless of what the U.S. Department of Health and Human Services (HHS) recommends. In a letter sent to Congressional Cannabis Caucus co-chair Rep. Earl Blumenauer (D-OR), DEA Acting Chief of […]| Marijuana Moment
A new scientific literature review published in the journal Molecules explores the “collaborative interactions” of various chemical compounds in marijuana—including cannabinoids, terpenes and flavonoids—arguing that a better understanding of the components’ combined effects “is crucial for unraveling cannabis’s complete therapeutic potential.” The findings reinforce what many in the marijuana space have been saying for years: […]| Marijuana Moment
The U.S. government has released hundreds of pages of documents related to its ongoing review of marijuana’s status under federal law, officially confirming for the first time that health officials have recommended the Drug Enforcement Administration (DEA) place cannabis in Schedule III of the Controlled Substances Act (CSA). The 252 pages of documents from the […]| Marijuana Moment